Cryoport, Inc. Form 8-K Summary
Business Context and Reporting Period
Cryoport, Inc. (CYRX), a Nevada corporation, filed this Current Report on Form 8-K on January 20, 2021, to disclose an underwritten public offering of common stock completed on January 25, 2021. The company is listed on The NASDAQ Stock Market LLC.
Key Financial Metrics
The filing details a capital raise event rather than periodic operating results. Key financial figures related to the transaction include:
- Shares Issued: 4,356,059 shares of common stock (including 568,181 shares from the full exercise of the underwriters' option).
- Offering Price: $66.00 per share.
- Net Proceeds: Approximately $269.7 million after deducting underwriting discounts, commissions, and estimated offering expenses.
- Revenue, Profit, and Margins: The filing text does not provide a clear value for revenue, profit, cash flow, or margins as this is a transaction report, not an earnings release.
- Debt and Liquidity: The filing text does not provide a clear value for existing debt levels or liquidity ratios, though the transaction significantly increases cash liquidity.
Material Changes
The primary material change is the increase in outstanding common stock and the influx of capital from the public offering. The company utilized an effective automatic shelf registration statement (File No. 333-251354) to facilitate the sale.
Outlook, Risks, and Management Commentary
The filing does not contain forward-looking guidance, management commentary on future operations, or specific risk factors beyond standard legal disclaimers regarding the Underwriting Agreement. The transaction was executed with Morgan Stanley & Co. LLC, Jefferies LLC, SVB Leerink LLC, and UBS Securities LLC as representatives of the underwriters.
Investor Verification Checklist
- Verify the final number of shares outstanding post-offering to assess dilution impact.
- Confirm the specific allocation of the $269.7 million net proceeds in subsequent filings (e.g., 10-Q or 10-K).
- Review the full Underwriting Agreement (Exhibit 1.1) for lock-up periods or specific covenants.
- Monitor stock price performance relative to the $66.00 offering price.